← All indications
Muscle Cramp
A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process (e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.). (From Adams et al., Principles of Neurology, 6th ed, p1398)
Drugs by status
Approved for this indication (11)
Phase 4 trials (7)
Phase 3 trials (2)
Phase 2 trials (3)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Other Experimental Indications (17)
- Orphelia Pharma SA
- United States Army
- Huazhong University of Science and Technology
- Institut National de la Santé Et de la Recherche Médicale, France
- Mansoura University
- McMaster University
- Queen Sirikit National Institute of Child Health
- University of Southern California
- Chinese University of Hong Kong
- University of British Columbia
- Vancouver Coastal Health
- University of Lyon
- Cantonal Hospital of St. Gallen
- University of Wisconsin
- University of Western Ontario
- National Research Agency, France
- Mayday Fund